Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.

 
Web www.patentalert.com

< Novel heterocyclic analogs of diphenylethylene compounds

< Novel substituted diamine derivatives useful as motilin antagonists

> Amide bridged piphenyl or biazaphenyl derivatives

> Benzoxazole carboxamides for treating CINV and IBS-D

~ 00284